News & Blog
Updates every week
-
Nagi Bioscience raises 12.4MCHF Series A round
28/09/23 – Press Release
Nagi Bioscience is thrilled to announce the successful closure of its Series A funding round co-led by Swisscanto and imec.xpand.
-
Nagi Bioscience receives the Innosuisse Certificate accrediting for sustainable growth
06/06/23 – Press Release
“This certification accredits that Nagi is fully ready to start scaling-up as commercial organization and to accomplish our mission of accelerating the transition to a new era of biological testing with our state-of-the-art technology.”
-
Nagi Bioscience launches Sydlab One
30/03/23 – Press Release
We are thrilled to announce the launch into the market of SydLab One: the first end-to-end automated high-content screening of substances on small organisms
-
The SERI-funded EIC Accelerator program grants Nagi Bioscience with €2.5 million to accelerate development and commercial scale-up of their unique ‘Organism-on-Chip’ product
21/03/22 – Press Release
Professing the transition to the new era of biological testing as our vision, being selected by the EIC Accelerator program is going to be crucial to make Nagi’s vision a reality.
-
Nagi Bioscience is proud to announce the closing of a CHF 1.8M seed financing round
20/12/19 – Press Release
Nagi Bioscience raises CHF 1.8 Million to accelerate its mission of setting a new standard for testing safety and efficacy of drugs and chemicals.
Let’s connect
Keen to hear about the latest news in the world of alternative testing methods? Are you interested in learning about the latest techniques in toxicology? Maybe a worm enthusiast?
Blog post, #ResearchAlerts, webinars, trending news, and much more in the Nagi Social Channels
Follow us
